PR
    Pharmacy Remedy

    Hospital, Oncology Centre and Procurement Supply in Bahrain

    Supplying licensed establishments in Bahrain: the documentation pack, batch traceability, cold chain and compliance with NHRA requirements. No pricing published.

    Prescription-only medicine. No pricing is published on this page. Prescription-medicine pricing is not advertised to the public in this market.

    This page is informational and is not an advertisement, a promotional communication, or medical advice. It does not offer any medicine for sale to the public. Treatment decisions belong to your treating physician.

    Who this page is for

    • Licensed government and private hospitals
    • Oncology centres and day-care treatment units
    • Licensed specialty pharmacies
    • Procurement and supply-chain departments

    The documentation pack that accompanies each consignment

    • Certificate of origin for the product
    • Manufacturer's batch certificate of analysis (CoA)
    • Proforma invoice stating trade name, active ingredient, concentration, quantity, batch numbers and expiry dates
    • Continuous temperature record for that specific consignment for refrigerated products (2–8 °C)
    • Batch traceability data, with pack-level GS1 DataMatrix verification available
    • Licensed Türkiye supplier details and responsible pharmacist details

    The regulatory position in Bahrain

    Medicines in the Kingdom of Bahrain are regulated by the National Health Regulatory Authority (NHRA).

    We have not verified Bahrain's personal-import procedure from a primary source, so we do not describe one. Requirements should be confirmed directly with the NHRA before any step is taken.

    What we can describe is the general concept that applies across the region: a named-patient supply. A named-patient supply is a quantity of a prescription medicine intended for one identified patient, requested by that patient's treating physician, documented by a prescription and a medical report, and handled through licensed channels with the cold chain and batch traceability intact. It is not a commercial sale to the public and it is not a substitute for a locally registered product where one is available.

    Gathering the documentation below before contacting the authority usually shortens the process, whichever route the NHRA confirms applies.

    We have not verified Bahrain's personal-import procedure. We do not describe one here. Confirm the current requirements with the NHRA.

    Official sources

    Background reading

    Prescription-based enquiry

    If you hold a valid prescription from a treating physician in Bahrain, you can send us the prescription details and we will reply with the regulatory and documentation position for that specific product. We do not publish pricing for Bahrain and we do not sell to the public.

    Send a prescription-based enquiry

    Medically reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-07-29